Guru Ownership Trend
Guru Analysis for Mineralys Therapeutics, Inc. (MLYS)
Mineralys Therapeutics, Inc. (MLYS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $71.79 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $24.06 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 298.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Mineralys Therapeutics, Inc. (MLYS)
Major holders include Steven Cohen ($51.78 M), Renaissance Technologies (RenTech) ($10.37 M), Paul Tudor Jones ($4.22 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.6 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $24.06 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited MLYS. The total reported sell value was $2.18 M.
Yes, 0 managers opened new positions in MLYS, and 4 increased their existing holdings. The total reported buy value was $26.23 M.